The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 340:1990-1991 June 24, 1999 Number 25
NextNext

Glucocorticoid Therapy for Chronic Obstructive Pulmonary Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Niewoehner, D. E.
-Related Article
 by Pauwels, R. A.
-PubMed Citation
Chronic obstructive pulmonary disease (COPD) refers to a group of disorders characterized by a persistent reduction in the maximal rate of exhalation despite aggressive treatment. In the United States, COPD was ranked as the fifth leading cause of death in 1989, and mortality rates are increasing, especially among women.1 The conditions best recognized as causing COPD — chronic bronchitis and emphysema — most often result from cigarette smoking and are typically coincident. Asthma also causes COPD; severe, irreversible airflow obstruction is found in some patients with a long history of asthma and no other identifiable risk factors.2 Indeed, evidence that . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.